{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:19:06Z","timestamp":1790299146231,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41429-019-0204-x","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T07:02:53Z","timestamp":1562914973000},"page":"759-768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process"],"prefix":"10.1038","volume":"72","author":[{"given":"Dat Huu","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Sugamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-7497","authenticated-orcid":false,"given":"Akihiro","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kawachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko S.","family":"Akagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"\u014cmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Sunazuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Mimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"204_CR1","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/00006454-199711000-00012","volume":"16","author":"WP Glezen","year":"1997","unstructured":"Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J. 1997;16:1065\u20138.","journal-title":"Pediatr Infect Dis J."},{"key":"204_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.1119392","volume":"310","author":"TM Tumpey","year":"2005","unstructured":"Tumpey TM. et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005;310:77\u201380.","journal-title":"Science"},{"key":"204_CR3","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa040419","volume":"350","author":"TH Tran","year":"2004","unstructured":"Tran TH. et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004;350:1179\u201388.","journal-title":"N Engl J Med"},{"key":"204_CR4","unstructured":"World Health Organization. Weekly update pandemic (H1N1) 2009. 6 August 2010. https:\/\/www.who.int\/csr\/don\/2010_08_06\/en\/."},{"key":"204_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1164\/rccm.200909-1420OC","volume":"181","author":"T Mauad","year":"2009","unstructured":"Mauad T. et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Cit Care Med. 2009;181:72\u20139.","journal-title":"Am J Respir Cit Care Med"},{"key":"204_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00540-012-1402-x","volume":"26","author":"S Takeda","year":"2012","unstructured":"Takeda S. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) severe respiratory failure in Japan. J Anesth. 2012;26:650\u20137.","journal-title":"J Anesth"},{"key":"204_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJM199709253371302","volume":"337","author":"FG Hayden","year":"1997","unstructured":"Hayden FG. et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. GG167 Influenza Study Group. N Engl J Med. 1997;337:874\u201380.","journal-title":"N Engl J Med"},{"key":"204_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3851\/IMP1688","volume":"21","author":"M Yamashita","year":"2010","unstructured":"Yamashita M. Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza. Antivir Chem Chemother. 2010;21:71\u201384.","journal-title":"Antivir Chem Chemother"},{"key":"204_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/596311","volume":"48","author":"I Stephenson","year":"2009","unstructured":"Stephenson I. et al. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis. 2009;48:389\u201396.","journal-title":"Clin Infect Dis"},{"key":"204_CR10","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01200-09","volume":"83","author":"AC Hurt","year":"2009","unstructured":"Hurt AC, Holien JK, Parker M, Kelso A, Barr IG. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol. 2009;83:10366\u201373.","journal-title":"J Virol"},{"key":"204_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/irv.12187","volume":"8","author":"SK Leang","year":"2014","unstructured":"Leang SK. et al. Peramivir and laninamivir susceptibility of circulating influenza A and B viruses. Influenza Other Respir Virus. 2014;8:135\u20139.","journal-title":"Influenza Other Respir Virus"},{"key":"204_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2183\/pjab.93.027","volume":"93","author":"Y Furuta","year":"2017","unstructured":"Furuta Y, Komeno T, Nakamura T. Favipiravir (T-705), a broad-spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B. 2017;93:449\u201363.","journal-title":"Proc Jpn Acad Ser B"},{"key":"204_CR13","first-page":"9","volume":"44","author":"ENg Kimberly","year":"2019","unstructured":"Kimberly ENg. Xofluza (Baloxavir Marboxil) for the treatment of acute uncomplicated influenza. P T Community. 2019;44:9\u201311.","journal-title":"P T Community"},{"key":"204_CR14","first-page":"1800698","volume":"24","author":"E Takashita","year":"2019","unstructured":"Takashita E. et al. Detection of influenza A (H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eur Surveill. 2019;24:1800698","journal-title":"Eur Surveill"},{"key":"204_CR15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0022-3565(24)29389-7","volume":"298","author":"M Tsurita","year":"2001","unstructured":"Tsurita M. et al. Early augmentation of interleukin (IL)-12 level in the airway of mice administrated orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J Pharm Exp Ther. 2001;298:362\u20138.","journal-title":"J Pharm Exp Ther"},{"key":"204_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1124\/jpet.109.162149","volume":"333","author":"M Yamaya","year":"2010","unstructured":"Yamaya M. et al. Clarithromycin inhibits type A seasonal influenza virus infection in human airway epithelial cells. J Pharm Exp Ther. 2010;333:81\u201390.","journal-title":"J Pharm Exp Ther"},{"key":"204_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ja.2013.132","volume":"67","author":"R Sugamata","year":"2014","unstructured":"Sugamata R. et al. Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression. J Antibiot. 2014;67:213\u201322.","journal-title":"J Antibiot"},{"key":"204_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69:531\u201369.","journal-title":"Annu Rev Biochem"},{"key":"204_CR19","unstructured":"Palese P, Shaw ML. Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1647\u201389."},{"key":"204_CR20","doi-asserted-by":"publisher","first-page":"L270","DOI":"10.1152\/ajplung.00011.2014","volume":"300","author":"B Yeganeh","year":"2015","unstructured":"Yeganeh B. et al. Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1. Am J Physiol Lung Cell Mol Physiol. 2015;300:L270\u201386.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"204_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm1571","volume":"6","author":"C Le Roy","year":"2005","unstructured":"Le Roy C, Wrana JL. Clathrin- and non- clathrin-mediated endocytosis regulation of cell signaling. Nat Rev Mol Cell Biol. 2005;6:112\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"204_CR22","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1073\/pnas.1812632116","volume":"116","author":"J Qin","year":"2019","unstructured":"Qin J. et al. Real-time dissection of dynamic uncoating of individual influenza viruses. Proc Natl Acad Sci USA. 2019;116:2577\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"204_CR23","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1128\/JVI.01705-10","volume":"85","author":"SL Londrigan","year":"2011","unstructured":"Londrigan SL. et al. N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN. J Virol. 2011;85:2990\u20133000.","journal-title":"J Virol"},{"key":"204_CR24","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/jmv.24911","volume":"89","author":"C Fage","year":"2017","unstructured":"Fage C, Pizzorno A, Rheaume C, Abed Y, Boivin G. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus. J Med Virol. 2017;89:2239\u201343.","journal-title":"J Med Virol"},{"key":"204_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1743-422X-7-53","volume":"7","author":"Y Matsuzaki","year":"2010","unstructured":"Matsuzaki Y. et al. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir. Virol J. 2010;7:53","journal-title":"Virol J"},{"key":"204_CR26","doi-asserted-by":"publisher","first-page":"e0119115","DOI":"10.1371\/journal.pone.0119115","volume":"10","author":"G Dong","year":"2015","unstructured":"Dong G. et al. Adamatane-resistant influenza A viruses in the world (1902-2013): frequency and distribution of M2 gene mutations. PloS ONE. 2015;10:e0119115","journal-title":"PloS ONE"},{"key":"204_CR27","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1001\/jama.2009.1583","volume":"302","author":"J Louie","year":"2009","unstructured":"Louie J. et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302:1896\u2013902.","journal-title":"JAMA"},{"key":"204_CR28","doi-asserted-by":"publisher","first-page":"e12557","DOI":"10.14814\/phy2.12557","volume":"3","author":"L Kalonji","year":"2015","unstructured":"Kalonji L. et al. The non-antibiotic macrolide EM900 inhibits rhinovirus infection and cytokine production in human airway epithelial cells. Physiol Rep. 2015;3:e12557","journal-title":"Physiol Rep"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0204-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0204-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0204-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:21:27Z","timestamp":1744176087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0204-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1038\/s41429-019-0204-x","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"2 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}